The briefing
Weill Cornell Medicine researchers report that a family of mutations found in about one-fifth of human cancers may drive malignancy by altering gene accessibility to a regulatory protein. The results suggest a unifying mechanism that could guide future diagnostics or therapies.
Original headline
A unifying mechanism for cancer-driving mutations